On The Insider: Garner-Affleck Baby Number 2
Find Articles in:
all
Business
Reference
Technology
News
Sports
Health
Autos
Arts
Home & Garden
advertisement
CIO SessionsVision Series on ZDNet

See and hear what CIOs the world over thinks about the business of technology and how it's changing the way we live and work.

Most Popular White Papers
advertisement

Content provided in partnership with
Thomson / Gale

Mitigating factor

Science News,  Feb 17, 2007  by Gregory V. Richardson

"Bitter Pill: Costs surge for new schizophrenia drugs" (SN: 12/9/06, p. 371) shares a common deficit with many other reports addressing cost-effectiveness of the medications used to treat schizophrenia. It is clearly true that the newer medications are much more expensive than the older ones, but tardive dyskinesia (TD) rates have plummeted by about 99 percent with the advent of the modern antipsychotic medications. To put it bluntly, TD is a form of brain damage. When these facts are presented to patients, they always prefer to try the modern antipsychotic medications.

GREGORY V. RICHARDSON, ANDERSON, IND.

COPYRIGHT 2007 Science Service, Inc.
COPYRIGHT 2008 Gale, Cengage Learning